Jared Freedberg - 01 Nov 2022 Form 4 Insider Report for INTERCEPT PHARMACEUTICALS, INC.

Role
General Counsel
Signature
/s/ Rocco Venezia, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
01 Nov 2022
Net transactions value
-$12,128
Form type
4
Filing time
03 Nov 2022, 16:01:50 UTC
Previous filing
03 Aug 2022
Next filing
03 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICPT Common Stock Tax liability $12,128 -771 -1.6% $15.73 48,192 01 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.